Adults with Obesity: Clinical Practice Guideline for Office Visits

Summary of the Endocrine Society's Guideline on the Pharmacological Management of Obesity

Written by J. Michael Gonzalez-Campoy MD, PhD, FACE

This article is the second in a 4-part series on the Endocrine Society’s clinical practice guideline on the pharmacological management of obesity. This section presents steps to take during an office visit for adults with obesity.  

The task force that developed the guidelines recommended that, for adults with obesity, the following be done during office visits:

Screen for the chronic co-morbid conditions:

Follow national cancer screening guidelines as adults with obesity are at increased risk for many types of cancer (including breast, esophagus, stomach, gallbladder and colon).

Look for potential contributing factors for obesity, including family history, sleep disorders, eating disorders, genetics, and environmental or socioeconomic causes.

Screen for the following secondary causes of obesity if history and/or physical examination suggest that these factors may play a role in the patient’s condition:

Follow the 2013 guidelines on management of overweight and obesity in adults issued by the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society:

June 6, 2015

Read other sections of the clinical practice guideline summary:

Sources

Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342-362.

Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985-3023.

Continue Reading

Pharmacological Management of Obesity: Agents and Mechanisms of Action